InnoCare Pharma Ltd. is a biopharmaceutical company engaged in the discovery, development, and commercialization of innovative treatments for diseases with substantial unmet clinical needs. Focused pr... InnoCare Pharma Ltd. is a biopharmaceutical company engaged in the discovery, development, and commercialization of innovative treatments for diseases with substantial unmet clinical needs. Focused primarily on oncology and autoimmune diseases, InnoCare develops a robust pipeline of targeted therapies designed to improve patient outcomes. Serving both the domestic and international markets, the company leverages cutting-edge research and development capabilities to advance the understanding of complex disease mechanisms. With a commitment to scientific excellence and patient-centric innovation, InnoCare collaborates extensively with global research institutions, enhancing its influence in the biopharmaceutical industry. Headquartered in China, InnoCare's strategic initiatives underscore its pivotal role in addressing critical health challenges and driving advancements in therapeutic solutions across medical disciplines.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

InnoCare Pharma is not subject to EU Taxonomy reporting

Based on current regulatory requirements, InnoCare Pharma is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review InnoCare Pharma's data?

Start your 30-day free trial to request a data review for InnoCare Pharma.

Start Free Trial

Legal Center Contact Us